Anticoccidial drugs market seen reaching $1.84 billion by 2030

By AI, Created 11:17 AM UTC, May 20, 2026, /AGP/ – The global anticoccidial drugs market is projected to grow from $1.35 billion in 2025 to $1.84 billion by 2030, driven by rising meat demand, expanding poultry farming and broader veterinary access. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Anticoccidial drugs help prevent and treat coccidiosis, a parasitic disease that can hurt poultry and livestock productivity. - The market’s growth reflects rising demand for animal protein and stronger pressure on farmers to protect animal health.

What happened: - The Business Research Company projected the anticoccidial drugs market will rise from $1.35 billion in 2025 to $1.45 billion in 2026. - The market is expected to reach $1.84 billion by 2030, with a 6.2% compound annual growth rate. - The company released the forecast from London on May 7, 2026. - A free sample of the report is available here. - The full market report is available here.

The details: - The market’s recent expansion has been driven by widespread coccidiosis in poultry, limited options among effective drug classes, rising demand for animal protein, traditional farming methods and greater awareness of animal health management. - Future growth drivers include innovations in drug delivery systems, more intensive poultry farming, broader veterinary service availability in emerging markets, government support for animal health and rising global demand for meat and poultry. - Expected trends include new anticoccidial formulations, greater focus on poultry health, wider use of combination therapies, expanded veterinary pharmaceutical distribution and tighter regulatory compliance. - Anticoccidial drugs target different stages of the parasite life cycle to control infection and prevent intestinal damage. - The drugs are used mainly in veterinary medicine to protect poultry and other livestock. - Growing demand for meat proteins is a major growth catalyst. - Meat And Livestock Australia Limited reported a 3.2% year-on-year increase in Australia’s red meat and livestock exports in 2024 to $19.5 billion. - USDA Economic Research Service data from April 2024 showed 178 million chickens were sold in the US in 2023, up 4% from the prior year. - US turkey populations also rose 4% in 2023, according to the same data. - Anticoccidial drugs are commonly added to poultry feed or water to protect birds during early growth stages. - Poultry farming is expanding because of higher protein demand, farm technology improvements and broader global trade. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a veterinary drug market tied closely to broader food-system trends, especially poultry expansion and consumer demand for meat. - The strongest growth is likely to come from regions where poultry production is scaling faster than veterinary infrastructure. - Combination therapies and new formulations suggest the market is moving toward more specialized disease management rather than simple prevention alone.

What’s next: - Watch for new product launches, distribution expansion and regulatory updates as the market moves toward 2030. - Asia-Pacific’s growth trajectory could narrow the gap with North America if poultry production and veterinary access continue to expand. - More reports from The Business Research Company are listed here.